E-cadherin may thus play a role in invasive capacity, but more data suggest other signalling mechanisms may be involved in earlier tumorigenic processes, especially cellular proliferation.
More and more data suggest that CSC play a significant role in tumor evasion of the several standard cancer treatment modalities.
Intermediate filament proteins have earlier been viewed as scaffolding structural proteins but more and more data suggest much more dynamic roles for these proteins [ 67].
In case of allogeneic transplantation, more data suggest preclinical and clinical evidence for a graft versus autoimmunity effect in replacement of a dysfunctional immune system by allogeneic HSCT, which also represents an attractive prospect.
More and more data suggest that substrate ambiguity, first defined in the classical patchwork model of Jensen [ 8], rather than catalytic promiscuity [ 9], is the main road which facilitates divergence of most enzyme families [ 10, 11].
However, more and more data suggest that ICL670, and probably L1, can be employed as effective alternative drugs, although it should be pointed out that most of this information stems from trials performed in non-MDS patients [ 42– 42].
